The therapeutic effect of 16 antimicrobial agents on Cryptosporidium infection in mice

Area of Science:

• Veterinary Parasitology
• Infectious Diseases
• Drug Discovery

Background:

• Cryptosporidium infections pose a significant threat to livestock, causing calf diarrhea and economic losses.
• Antimicrobial agents are commonly used to combat parasitic infections, but their efficacy against Cryptosporidium requires thorough investigation.

Purpose of the Study:

• To assess the therapeutic efficacy of sixteen distinct antimicrobial agents against Cryptosporidium infections in a murine model.
• To determine if any of the selected drugs could prevent or modify the course of Cryptosporidium infection.

Main Methods:

• A Cryptosporidium strain, isolated from a calf diarrhea outbreak, was used to infect mice.
• The infected mice were treated with one of the sixteen antimicrobial agents: Ethopabate, Nicarbazin, Sulphaquinoxaline, Furaltadone, Enterolyte-N, Sulphamethazine, Trinamide, Amprol, Phenamidine, Zoaquin, Halofuginone, Salinomycin, Monensin, Emtryl, Arprinocid, and Amprolium.
• Treatment outcomes were compared to those of infected, untreated control mice.

Main Results:

• None of the sixteen evaluated antimicrobial agents demonstrated any therapeutic effect.
• The drugs failed to prevent the onset of Cryptosporidium infection in the mice.
• The course of the infection was not modified in the treated groups compared to the control group.

Conclusions:

• The tested antimicrobial agents, including Ethopabate, Nicarbazin, and Amprolium, are ineffective against Cryptosporidium infections in this mouse model.
• Further research is needed to identify effective treatments for Cryptosporidium infections in both animals and humans.
• The findings highlight the urgent need for novel therapeutic strategies to combat cryptosporidiosis.